Latest revenue
$0
as of 2026-03-31
Latest net income
$-26.1M
as of 2026-03-31
Net margin
—
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $175.5M
- Enterprise value
- $175.5M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $3.06
- 52-wk low
- $1.00
- Beta
- —
- Shares out
- 124.5M
5-year trend
About MIST
Business description and risk factors will appear here once MIST's latest filing is fully ingested.
Profitability
Operating margin
-4019.4%
34.2%Net margin
-4078.8%
31.7%Return on equity
-479.6%
51.9%Return on assets
-55.5%
1.0%Leverage
Debt / equity
7.64×
61.0%Long-term debt / equity
4.35×
7.2%Debt / assets
88.4%
7.1%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $0 | — | $-26.1M | -25.6% | — |
Q4 2025 2025-12-31 | $1.5M | — | $-17.4M | -40.8% | -1126.1% |
Q3 2025 2025-09-30 | $0 | — | $-11.9M | -26.3% | — |
Q2 2025 2025-06-30 | $0 | — | $-13.0M | -38.5% | — |
Q1 2025 2025-03-31 | $0 | — | $-20.8M | -100.5% | — |
Q4 2024 2024-12-31 | $0 | — | $-12.4M | — | — |
Q3 2024 2024-09-30 | $0 | — | $-9.4M | +37.4% | — |
Q2 2024 2024-06-30 | $0 | — | $-9.4M | +41.6% | — |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Pharmaceutical Preparations · SIC 2834
Your notes
Keep private notes on MIST — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$0
Insider selling
$1.2M
Net activity
−$1.2M
Distinct insiders
5
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns MIST
Institutional value
$4.3M
Total shares held
3.8M
Distinct holders
43
-35 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | Simplify Asset Management Inc. | 1.5M | $1.8M | +0 (+0.0%) | No change |
| 2 | UBS Group AG | 494.9K | $588.9K | +3.0K (+0.6%) | Added |
| 3 | Aptus Capital Advisors, LLC | 280.3K | $333.5K | +17.1K (+6.5%) | Added |
| 4 | LPL Financial LLC | 193.4K | $230.1K | +50.9K (+35.7%) | Added |
| 5 | BNP PARIBAS FINANCIAL MARKETS | 176.5K | $210.0K | -45.4K (-20.5%) | Trimmed |
| 6 | JANE STREET GROUP, LLC | 159.7K | $190.0K | -933.6K (-85.4%) | Trimmed |
| 7 | Valeo Financial Advisors, LLC | 130.7K | $155.5K | +0 (+0.0%) | No change |
| 8 | GROUP ONE TRADING LLC | 129.8K | $154.4K | -65.3K (-33.5%) | Trimmed |
| 9 | TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 100.0K | $119.0K | +0 (+0.0%) | No change |
| 10 | October Effect Ltd | 52.0K | $61.8K | -150 (-0.3%) | Trimmed |
| 11 | Invesco Ltd. | 41.4K | $49.2K | +19.5K (+88.9%) | Added |
| 12 | Mariner, LLC | 30.8K | $36.7K | +5.8K (+23.3%) | Added |
| 13 | Bay Rivers Group | 29.9K | $35.6K | +1.1K (+3.6%) | Added |
| 14 | WELCH & FORBES LLC | 25.0K | $29.8K | — | New |
| 15 | Stephenson & Company, Inc. | 20.0K | $23.8K | +0 (+0.0%) | No change |
| 16 | JOURNEY STRATEGIC WEALTH LLC | 20.0K | $23.8K | +0 (+0.0%) | No change |
| 17 | Pathstone Holdings, LLC | 17.0K | $20.3K | -1.0M (-98.3%) | Trimmed |
| 18 | Exit Wealth Advisors, LLC. | 15.0K | $17.9K | — | New |
| 19 | Vision Retirement, LLC | 15.0K | $17.9K | — | New |
| 20 | SJS Investment Consulting Inc. | 15.0K | $17.9K | +0 (+0.0%) | No change |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once MIST's latest filing finishes processing.